Related Experiment Video
Updated: Jul 13, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Multiparametric risk stratification in patients with mild to moderate chronic heart failure
Angela Beatrice Scardovi1, Renata De Maria, Claudio Coletta
1Department of Cardiology, S. Spirito Hospital, Rome, Italy.
Insights
Combining cardiopulmonary exercise tests and echocardiography offers superior risk prediction in heart failure patients compared to brain natriuretic peptide alone. These multiparametric approaches improve prognostic stratification for better patient management.
Area of Science:
- Cardiology
- Pulmonology
- Geriatrics
Background:
- Prognostic stratification in mild-to-moderate systolic heart failure (HF) remains challenging.
- The combined utility of brain natriuretic peptide (BNP), cardiopulmonary exercise testing (CPx), and echocardiography is not fully understood.
Purpose of the Study:
- To evaluate the prognostic value of BNP, CPx-derived parameters, and echocardiographic findings in predicting outcomes in patients with mild-to-moderate systolic HF.
- To determine if a multiparametric approach improves risk stratification compared to individual markers.
Main Methods:
- A cohort of 244 stable outpatients with NYHA Class I-III HF and LVEF < 45% underwent BNP measurement, Doppler echocardiography, and maximal CPx.
- Follow-up for 18 months assessed all-cause mortality or HF re-hospitalization.
- Statistical analysis included Cox proportional hazards models to identify independent predictors.
Main Results:
- BNP levels, NYHA Class III, creatinine clearance, and hemoglobin predicted outcomes.
- Restrictive filling pattern (RFP) on echocardiography (HR 3.36) and enhanced ventilatory response to exercise (EVR, HR 1.50) outperformed BNP (HR 1.35) as prognostic markers.
- Patients with both RFP and EVR had a significantly higher risk (HR 7.30) of death or HF admission.
Conclusions:
- A multiparametric approach integrating echocardiography and CPx is crucial for optimal risk stratification in elderly patients with mild-to-moderate HF.
- High-risk patients identified by these methods require closer monitoring and tailored therapeutic strategies, including non-pharmacologic options.
Background:
Whether brain natriuretic peptide (BNP) combined with cardiopulmonary exercise test (CPx) and echocardiographic findings improves prognostic stratification in mild-to-moderate systolic heart failure (HF) is unclear.
Methods And Results:
A total of 244 consecutive stable outpatients, median age of 71 (62-76) years, with New York Heart Association (NYHA) Class I-III HF and left ventricular ejection fraction (LVEF) < 45% underwent BNP measurement, Doppler echocardiography, and a maximal CPx. Median BNP was 166 (70-403) pg/mL, median LVEF 35% (28%-40%). A restrictive filling pattern (RFP) was present in 44 patients (18%). At CPx, peak oxygen uptake was 12 (9.7, 14.4) mL/kg/min and an enhanced ventilatory response to exercise (EVR, slope of the ventilation to CO2 production ratio, > or = 35) was found in 90 patients (37%) During 18 (9-37) follow-up months, 80 patients died or were admitted for worsening HF (33%). In addition to simple bedside clinical variables (NYHA Class III, creatinine clearance, hemoglobin), BNP levels were predictive of outcome (HR 1.35 [1.12-1.63]). However, both RFP (HR 3.36 [2.09-5.41]) and a steeper minute ventilation-carbon dioxide output slope (HR 1.50 [1.19-1.88]) outperformed BNP as prognostic markers. Patients with both RFP and EVR had a 7.30 (95% CI 4.02-13.25) HR for death or HF-admission versus subjects with neither predictor.
Conclusions:
This study highlights the importance of a multiparametric approach for optimal risk stratification in the elderly with mild-to-moderate HF. Patients at high risk should undergo closer follow-up and be carefully evaluated for different therapeutic options, including nonpharmacologic treatment.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology